²é¿´: 227  |  »Ø¸´: 3
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
¡¾ÐüÉͽð±Ò¡¿»Ø´ð±¾ÌûÎÊÌ⣬×÷Õßzh4403½«ÔùËÍÄú 5 ¸ö½ð±Ò
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zh4403

Í­³æ (СÓÐÃûÆø)

[ÇóÖú] ÇóÖúAL-6589µÄ»¯Ñ§½á¹¹Ê½£¬TafluprostµÄÖÐÎÄÃû³Æ£¿¡¾ÓÐЧÆÚÖÁ2008Äê7ÔÂ18ÈÕ¡¿

ÇóÖúAL-6589µÄ»¯Ñ§½á¹¹Ê½£¬TafluprostµÄÖÐÎÄÃû³Æ£¿
AL-6589ºÃÏñÊÇÒ»ÖÖ¿¹Çà¹âÑÛÒ©£¬µ«ÊÇÎÒÕÒ²»µ½Æä»¯Ñ§½á¹¹£¬ÄÇλ°ïÎÒÕÒÏ¡£ÄÜ·ñÒÔMOL¸ñʽ±£´æÏ£¬ÎÒÓÃCHEMOFFICEºÃÖ±½Ó¶ÁÈ¡¡£
ÎÄÏ×¼û£ºToris, C. B., G. L. Zhan, et al. (2006). "Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous humor dynamics in a nonhuman primate model of glaucoma." J Ocul Pharmacol Ther 22(2): 86-92.

[ Last edited by zzgyb on 2008-8-18 at 15:21 ]

» ²ÂÄãϲ»¶

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

maomao3323

ľ³æ (ÖøÃûдÊÖ)

´Ï´Ï¼Ò×åÖ®´Ò´Òëë

ÖÐÎÄÃûÖ»¿´µ½
Ëû·úǰÁÐËØ
ÕâÒ»¸ö£¬²»ÖªµÀ×¼²»×¼
ÖÐÎĹØÓÚ´Ë»¯ºÏÎïµÄÎÄÏײ»Ì«¶à
MJ һ·×ߺÃ
3Â¥2008-07-12 05:48:47
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 4 ¸ö»Ø´ð

maomao3323

ľ³æ (ÖøÃûдÊÖ)

´Ï´Ï¼Ò×åÖ®´Ò´Òëë

¡ï ¡ï
liu2004m(½ð±Ò+2,VIP+0):лл£¡
½á¹¹Ê½°ïÄãÕÒµ½ÁË£¬ÔÚpubmed compoundÉϾÍÓÐ
¸øÄã¸öÁ´½Ó
http://pubchem.ncbi.nlm.nih.gov/ ... 5062&loc=ec_rcs

ÖÐÎÄÃûûÕÒµ½
MJ һ·×ߺÃ
2Â¥2008-07-12 05:39:29
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

maomao3323

ľ³æ (ÖøÃûдÊÖ)

´Ï´Ï¼Ò×åÖ®´Ò´Òëë

²»ºÃÒâ˼¸Õ¿ªÊ¼¿´´íÌâÄ¿ÁË
ÊÇAL-6589µÄ½á¹¹Ê½
ÔÙ°ïÄãÕÒÕÒ

ÕâÆªÎÄÏ×ÃèÊöÁËAl-6589µÄ½á¹¹À´Ô´
http://www.ncbi.nlm.nih.gov/pubm ... nel.Pubmed_RVDocSum

´ÓZK 118.182 (9beta-chloro-15-cyclohexyl-3-oxa-omega-pentanor PGF(2alpha)) ¿ªÊ¼

PGFµÄ½á¹¹Ê½
http://pubchem.ncbi.nlm.nih.gov/ ... 3586&loc=ec_rcs
±àºÅ´Ó×ó±ßôÈ»ù¿ªÊ¼£¬ÓұߵÄË«¼üÊÇ13£¬14£¬Ä©Î²ÊÇ20£¨Ïê¼û¸½Í¼£©

²ÎÕÕ»¯ºÏÎreference compound£©½á¹¹¾ÍÊÇ9λ±ä³ÉClÔ­×Ó£¬15λÁ¬½Ó»·¼º»ù£¬3λC»»³ÉO£¨ÑõÔÓ£©¡£

²ÎÕÕ»¯ºÏÎïµÄ13£¬14λµÄÏ©¼ü±¥ºÍ¾Í³ÉΪAL-6556

AL-6556µÄôÈ»ùÐγÉÒì±ûõ¥¾ÍÊÇAL-6598


¼ÒÀïµÄµçÄÔûÓл­½á¹¹Ê½µÄÈí¼þ
Ä㽫¾Í½«¾Í¿´¿´Ò²²î²»¶à¡£

ÎļþÃû: imgsrv.png
ÃèÊö: imgsrv.png
ÏÂÔØÁ´½Ó: http://www.fs2you.com/files/b6f270ae-4f9a-11dd-9a32-001143e7b41c/
Ô¤ÀÀ:
MJ һ·×ߺÃ
4Â¥2008-07-12 06:42:11
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²»Ó¦Öú È·¶¨»ØÌûÓ¦Öú (×¢Ò⣺ӦÖú²Å¿ÉÄܱ»½±Àø£¬µ«²»ÔÊÐí¹àË®£¬±ØÐëÌîд15¸ö×Ö·ûÒÔÉÏ)
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 308Çóµ÷¼Á +3 °¢½ã°¢½ã¼Ò°¡ 2026-03-18 3/150 2026-03-20 23:24 by JourneyLucky
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤ 322Çóµ÷¼Á +4 È»11 2026-03-19 4/200 2026-03-20 22:12 by luoyongfeng
[¿¼ÑÐ] 0817 »¯Ñ§¹¤³Ì 299·ÖÇóµ÷¼Á ÓпÆÑо­Àú ÓжþÇøÎÄÕ +22 rare12345 2026-03-18 22/1100 2026-03-20 20:39 by zhukairuo
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á £¬Áù¼¶Òѹý£¬ÓпÆÑо­Àú +13 êØÎõÙâ 2026-03-15 13/650 2026-03-20 19:35 by Dream007008
[¿¼ÑÐ] »·¾³¹¤³Ìµ÷¼Á +9 ´ó¿Édigkids 2026-03-16 9/450 2026-03-20 17:38 by ×íÔÚ·çÀï
[¿¼²©] ÕÐÊÕ²©Ê¿1-2ÈË +3 QGZDSYS 2026-03-18 3/150 2026-03-20 11:58 by ßÉßÉßÉßɽÐ
[¿¼ÑÐ] 304Çóµ÷¼Á +5 ÂüÊâ2266 2026-03-18 5/250 2026-03-20 09:00 by ZHANG0tao
[¿¼ÑÐ] ²ÄÁÏר˶ӢһÊý¶þ306 +6 z1z2z3879 2026-03-18 6/300 2026-03-20 08:49 by xingguangj
[ÂÛÎÄͶ¸å] ÉêÇë»Ø¸åÑÓÆÚÒ»¸öÔ£¬±à¼­Í¬ÒâÁË¡£µ«ÏµÍ³ÉϵÄʱ¼äû±ä£¬¸ø±à¼­ÓÖдÓʼþÁË£¬Ã»»Ø¸´ 10+3 wangf9518 2026-03-17 4/200 2026-03-19 23:55 by babero
[¿¼ÑÐ] Ò»Ö¾Ô¸Öйúº£Ñó´óѧ£¬ÉúÎïѧ£¬301·Ö£¬Çóµ÷¼Á +5 1ËïÎò¿Õ 2026-03-17 6/300 2026-03-19 23:46 by zcl123
[¿¼ÑÐ] 0703»¯Ñ§µ÷¼Á£¬Çó¸÷λÀÏʦÊÕÁô +10 ÇïÓÐľ±± 2026-03-14 10/500 2026-03-19 05:52 by anny19840123
[¿¼ÑÐ] ²ÄÁÏר˶306Ó¢Ò»Êý¶þ +10 z1z2z3879 2026-03-16 13/650 2026-03-18 14:20 by 007_lilei
[¿¼ÑÐ] 303Çóµ÷¼Á +4 î£08 2026-03-17 6/300 2026-03-18 11:01 by Iveryant
[¿¼ÑÐ] ÉúÎïѧ071000 329·ÖÇóµ÷¼Á +3 ÎÒ°®ÉúÎïÉúÎﰮΠ2026-03-17 3/150 2026-03-18 10:12 by macy2011
[¿¼²©] 26²©Ê¿ÉêÇë +3 1042136743 2026-03-17 3/150 2026-03-17 23:30 by ÇáËɲ»ÉÙËæ
[¿¼ÑÐ] 290Çóµ÷¼Á +3 p asserby. 2026-03-15 4/200 2026-03-17 16:35 by wangkm
[¿¼ÑÐ] [µ¼Ê¦ÍƼö]Î÷ÄϿƼ¼´óѧ¹ú·À/²ÄÁϵ¼Ê¦ÍƼö +3 ¼â½ÇСºÉ 2026-03-16 6/300 2026-03-16 23:21 by ¼â½ÇСºÉ
[¿¼ÑÐ] 326Çóµ÷¼Á +3 mlpqaz03 2026-03-15 3/150 2026-03-16 07:33 by Iveryant
[¿¼ÑÐ] 288Çóµ÷¼Á +4 Ææµã0314 2026-03-14 4/200 2026-03-14 23:04 by JourneyLucky
[¿¼ÑÐ] 289Çóµ÷¼Á +4 ÕâôÃû×ÖÕ¦Ñù 2026-03-14 6/300 2026-03-14 18:58 by userper
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û